Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 4 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
Am J Hematol. 2023 May;98(5):760-769. doi: 10.1002/ajh.26892. Epub 2023 Mar 13.
Am J Hematol. 2023.
PMID: 36861732
Free article.
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.
Lee WH, Tsai MT, Tsai CH, Tien FM, Lo MY, Tseng MH, Kuo YY, Liu MC, Yang YT, Chen JC, Tang JL, Sun HI, Chuang YK, Lin LI, Chou WC, Lin CC, Hou HA, Tien HF.
Lee WH, et al.
Blood Cancer J. 2023 Aug 9;13(1):120. doi: 10.1038/s41408-023-00894-8.
Blood Cancer J. 2023.
PMID: 37558665
Free PMC article.
Item in Clipboard
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
Lee WH, Lin CC, Tsai CH, Tien FM, Lo MY, Tseng MH, Kuo YY, Yu SC, Liu MC, Yuan CT, Yang YT, Chuang MK, Ko BS, Tang JL, Sun HI, Chuang YK, Tien HF, Hou HA, Chou WC.
Lee WH, et al.
Blood Cancer J. 2024 Apr 9;14(1):57. doi: 10.1038/s41408-024-01031-9.
Blood Cancer J. 2024.
PMID: 38594285
Free PMC article.
Item in Clipboard
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations.
Tien FM, Yao CY, Tsai XC, Lo MY, Chen CY, Lee WH, Lin CC, Kuo YY, Peng YL, Tseng MH, Wu YS, Liu MC, Lin LI, Chuang MK, Ko BS, Yao M, Tang JL, Chou WC, Hou HA, Tien HF.
Tien FM, et al. Among authors: lee wh.
Blood Cancer J. 2024 Jan 23;14(1):15. doi: 10.1038/s41408-023-00975-8.
Blood Cancer J. 2024.
PMID: 38253683
Free PMC article.
Item in Clipboard
Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients.
Lee WH, Lin CC, Tsai CH, Tseng MH, Kuo YY, Liu MC, Tang JL, Sun HI, Chuang YK, Chou WC, Hou HA, Tien HF.
Lee WH, et al.
Am J Hematol. 2022 Dec;97(12):1589-1598. doi: 10.1002/ajh.26734. Epub 2022 Oct 10.
Am J Hematol. 2022.
PMID: 36109871
Free article.
Item in Clipboard
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.
Lee WH, Lin CC, Wang YH, Yao CY, Kuo YY, Tseng MH, Peng YL, Hsu CA, Sun HI, Chuang YK, Hsu CL, Tien FM, Tsai CH, Chou WC, Hou HA, Tien HF.
Lee WH, et al.
Hematol Oncol. 2023 Aug;41(3):463-473. doi: 10.1002/hon.3109. Epub 2022 Nov 30.
Hematol Oncol. 2023.
PMID: 36420747
Item in Clipboard
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
Lee WH, Lin CC, Tsai CH, Tien FM, Lo MY, Ni SC, Yao M, Tseng MH, Kuo YY, Liu MC, Tang JL, Sun HI, Chuang YK, Chou WC, Hou HA, Tien HF.
Lee WH, et al.
Am J Hematol. 2023 Mar;98(3):398-407. doi: 10.1002/ajh.26799. Epub 2023 Jan 1.
Am J Hematol. 2023.
PMID: 36588411
Free article.
Item in Clipboard
Cite
Cite